Four grid table. حسب Xiaoling Zhong (181270)

الموضوعات:

Flowchart depicting the selection of the study population. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the PT level (age < 18). حسب Xiaoling Zhong (181270)

الموضوعات:

Basic information and patient characteristics according to the report. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the preferred term level in the FAERS database. حسب Xiaoling Zhong (181270)

الموضوعات:

Four major algorithms used for signal detection. حسب Xiaoling Zhong (181270)

الموضوعات:

Time to onset of AEs in male and female patients receiving finasteride therapy. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the SOC level. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the SOC level حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration in female at the PT level. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration in male at the PT level. حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the PT level (age = 18-65). حسب Xiaoling Zhong (181270)

الموضوعات:

Signal strength of reports of finasteride administration at the PT level (age>=65). حسب Xiaoling Zhong (181270)

الموضوعات:

Clinical characteristics of reports with finasteride as the primary suspected drug from the FAERS database. حسب Xiaoling Zhong (181270)

الموضوعات:

Sex-differentiated risk signal volcano plot for finasteride. حسب Xiaoling Zhong (181270)

الموضوعات:

Number of adverse reaction case reports of finasteride administration at the PT level. حسب Xiaoling Zhong (181270)

الموضوعات:

WT data of set A398E/V and set M1425V/I pooled for better comparison. حسب Yousra El Ghaleb (22075892)

Fig 4 - حسب Leena Inkilä (20614460)

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. حسب Yousra El Ghaleb (22075892)

Table 1_Altered Th17/Treg balance and therapeutic targeting of RORγ in primary focal hyperhidrosis.docx حسب Min Lin (17652)

"…Elevated IL-17 and IL-6 and reduced IL-10 and TGF-β1 levels were observed in PFH serum. Sweat glands showed increased RORγt and decreased FOXP3 expression. …"